Workshop B: How AI Could Change the Way We Manage Benign Haematology Patients
Tracks
Plenary Hall
| Sunday, March 29, 2026 |
| 10:15 AM - 11:15 AM |
Speaker
Dr. Drew Provan
Emeritus Reader in Haematology
Barts & The London School of Medicine, Queen Mary University of London
Workshop B: How AI Could Change the Way We Manage Benign Haematology Patients
10:15 AM - 11:15 AMBiography
Dr. Drew Provan is Emeritus Reader in Autoimmune Haematology at Barts and The London School of Medicine and Dentistry. He originally studied molecular genetics before training in medicine, and later undertook research at the Dana–Farber Cancer Institute in Boston as an MRC Travelling Fellow.
Dr Provan is a leading authority in immunohaematology, with a major focus on immune thrombocytopenia, neutropenia and haemolytic anaemia. He helped establish the UK ITP Registry and is a senior author of the International Consensus Guidelines for the diagnosis and management of ITP in adults and children.
He has published extensively in the field and is author of several well-known medical texts, including Molecular Haematology, the Oxford Handbook of Clinical Haematology, and the ABC of Clinical Haematology.